Trials (Radboudumc Centre for Oncology): Revision history

15 December 2025

• curprev 17:2417:24, 15 December 2025‎ Francine talk contribs‎ 11,819 bytes +176‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 11,643 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:3717:37, 4 December 2025‎ Larysse talk contribs‎ 9,942 bytes +56‎ No edit summary undo

2 December 2025

• curprev 14:0014:00, 2 December 2025‎ Lucas talk contribs‎ m 9,886 bytes +90‎ Update categories. undo

5 December 2023

• curprev 18:5518:55, 5 December 2023‎ Francine talk contribs‎ 9,796 bytes +9,796‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Radboudumc Centre for Oncology page '''NCTID''': NCT01322490 '''Title''': A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer '''Study Summary''': The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall surv..."